Skip to main content
COVID-19
Updates to pre-operation screening processes from 12 September 2022
Acknowledgement
The Women's and Children's Hospital is located on the traditional lands for the Kaurna people, and we respect their spiritual relationship with their Country. We also acknowledge that the Kaurna people are the custodians of the Adelaide region, and that their cultural and heritage beliefs are still as important to the living Kaurna people today.

Aboriginal and Torres Strait Islander people should be aware that this website may contain images, voices and names of people who have passed away.

If you are interested in taking part in one of our current clinical trials, please call (08) 8161 6328 for further information.

Current Trials

FluBub Study

Do you have a new baby who is yet to receive their first scheduled vaccinations?

The Women’s and Children’s Hospital and University of Adelaide are looking for healthy mums and their young babies to take part in an important study aiming to give young babies vital protection against Influenza.

Babies are at risk of life-threatening complications from influenza. The FluBub study will investigate whether giving babies the influenza vaccine, licensed and recommended from 6 months of age, earlier will provide much-needed protection from influenza.

If you have a new baby who is yet to receive their first scheduled vaccinations, we would love to hear from you. To find out more contact virtu@adelaide.edu.au or call Donna Martin on 8161 6328.

Recruitment status: Currently recruiting

PICOBOO: COVID-19 Vaccine Boosting

Are you:

  • A teenager aged 12 - 17 who has received two COVID-19 vaccinations and would like to be one of the first in this age group to have a booster dose?
  • An adult aged under 50 who has received your first two COVID-19 vaccinations but has not yet had your first booster dose?
  • An adult aged 18 or over who has already received three COVID-19 vaccinations and is interested in having a second booster dose?

The Vaccinology and Immunology Research Trials Unit (VIRTU) at the Women’s and Children’s Hospital is investigating the most effective, long-term strategies for booster vaccinations to find out whether:

  • Immunity can be maximised by ‘mixing' vaccine booster types and how long this protection lasts.
  • How strategies may need to differ depending on age and previous COVID-19 vaccines.

For more information about PICOBOO, please email VIRTU@adelaide.edu.au or call Meredith Krieg on 8161 7349 or Arockia Sugantharaj on 8161 7452.

You can also fill in an Expression of interest form:

This study has been approved by the Child and Adolescent Human Research Ethics Committee. Any person with concerns or complaints about the conduct of this study should contact the Executive Director of Medical Services via [08 6456 2222] who can refer your concerns to the HREC monitoring the project.

Recruitment status: Currently recruiting

COVALIA COVID-19 Vaccine Trial

Description: Looking at the safety and immune response of a new investigational vaccine against COVID-19, which is being administered using needle-free technology.

Age group: healthy adults aged 18-75 years

Recruitment status: Currently recruiting

Paediatric Active Enhanced Disease Surveillance (PAEDS)

Description: Hospital-based active surveillance for childhood conditions of public health importance.

Age group: 0–18 years

Maternal RSV Study

Pregnant Volunteers required for a Respiratory Syncytial Virus Investigational vaccine study

The Vaccinology and Immunology Research Trials Unit at the Women’s and Children’s Hospital is participating in a research study on Respiratory Syncytial Virus (RSV) and is looking for pregnant volunteers to take part to find out whether giving an investigational vaccine during pregnancy may help protect babies against RSV infection. RSV is a common cause of respiratory illness, especially in babies under 12 months of age.

You may be eligible to participate if you are:

  • Aged 18 to 49 years
  • Are of general good health
  • Are expecting a single healthy baby
  • Are between 24 and 36 weeks pregnant on the day of planned vaccination

You will need to meet other requirements to participate and the study team will discuss these with you.

If eligible, your participation in this study will take place during your pregnancy and for approximately 12–24 months after your baby is born. You and your baby will be required to visit the study doctor at the Women’s and Children’s Hospital a number of times for follow-up and to provide information about your and your baby’s health.

For more information or to assess eligibility please contact:

Louise Goodchild
Phone 8161 6328 or email VIRTU@adelaide.edu.au

Recruitment status: Currently recruiting

All information is kept strictly confidential. There are no costs associated with participation, and travel expenses can be reimbursed. This study has been approved by a Human Research Ethics Committee.

B Part Of It – School Leaver Study

Description: Looks at the impact of Meningococcal B (Men B) vaccination in older adolescents and offered free Men B vaccine.

Age group: School years 10, 11 and 12

Recruitment status: Currently recruiting

Maternal Vaccination Uptake

Description: Maternal vaccination uptake in women who deliver at the Women's and Children's Hospital: a medical case note audit.

Age group: Women who delivered in August 2016

Recruitment status: Currently recruiting

WHO Influenza

Description: Collection of pre- and post-vaccination blood samples from volunteers receiving the annual Southern Hemisphere formulation of inactivated Influenza vaccine.

Age group: Staff and volunteers of the Women's and Children's Hospital

Recruitment status: Currently recruiting